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Abstract: We have demonstrated previously that L-glutamate 
is taken up into isolated synaptic vesicles in an ATP-depen- 
dent manner, supporting the neurotransmitter role of this 
acidic amino acid. We now report that a nerve terminal cy- 
tosolic factor inhibits the ATP-dependent vesicular uptake 
of glutamate in a dose-dependent manner. This factor appears 
to be a protein with a molecular weight >100,000, as esti- 
mated by size exclusion chromatography, and is precipitated 
by ammonium sulfate (40% saturation). The inhibitory factor 
is inactivated by heating to 100°C. Proteolytic digestion of 
the ammonium sulfate fraction by trypsin or chymotrypsin 
did not reduce, but rather increased slightly, the inhibition 
of glutamate uptake. Unlike the native factor, the digest re- 
tained inhibitory activity after heating, suggesting that pro- 
teolytic digestion may generate active fragments. The inhi- 
bition of ATP-dependent vesicular glutamate uptake is not 
species-specific, as the factor obtained from both rat and bo- 
vine brains produced an equal degree of inhibition of glu- 
tamate uptake into vesicles of each species. These observations 
raise the possibility that vesicular uptake of glutamate may 
be regulated by an endogenous factor in vivo. Key Words: 
Glutamate uptake-Vesicles-Cytosolic factor. Lobur A. T. 
et al. Synaptic vesicular glutamate uptake: Modulation by a 
synaptosomal cytosolic factor. J.  Neurochem. 54, 16 14- 
1618 (1990). 
Glutamate is now widely accepted as the major ex- 
citatory neurotransmitter in the vertebrate CNS, as well 
as in the invertebrate neuromuscular junction (Watkins 
and Evans, 1981; Fonnum, 1984; Fagg et al., 1986; 
Cotman et al., 1987, 1989). Abnormalities in gluta- 
matergic transmission have been implicated in a variety 
of neurological disorders, including epilepsy, ischemia- 
induced neuronal degeneration, Huntington’s chorea, 
and Alzheimer’s disease (Meldrum, 1985; Greenamyre, 
1986; Olney et al., 1986; Robinson and Coyle, 1987; 
Rothman and Olney, 1987). We and others have pro- 
vided evidence that glutamate is taken up into isolated 
synaptic vesicles in an ATP-dependent manner (Naito 
and Ueda, 1983, 1985; Maycox et al., 1988), further 
supporting the role of glutamate as a neurotransmitter. 
This vesicular uptake system is highly specific for glu- 
tamate and is markedly stimulated by physiologically 
relevant, low millimolar concentrations of chloride. 
Based on the high degree of substrate specificity and 
on other unique properties of the vesicular glutamate 
uptake system, it has been proposed that the fate of 
glutamate as a neurotransmitter is determined at the 
level of vesicular uptake (Ueda, 1986). The evidence 
for the vesicular uptake of glutamate is in accord with 
the immunocytochemical observation that glutamate 
is concentrated in certain nerve endings, which are dis- 
tinct from y-aminobutyric acid (GABA)-containing 
nerve terminals (Storm-Mathisen et al., 1983). Nicholls 
and Sihra (1 986) have provided evidence that calcium- 
dependent release of glutamate originates from a non- 
cytoplasmic pool. Together, these lines of evidence 
support the idea that glutamate is released from syn- 
aptic vesicles. Also consistent with this idea are studies 
(Fischer-Bovenkerk et al., 1988) indicating that the 
ATP-dependent vesicular uptake system is present in 
cerebellar granule cells, which are considered to be glu- 
tamatergic, but not in GABAergic Purkinje neurons. 
Moreover, it has been demonstrated recently that the 
ATP-dependent vesicular glutamate uptake system de- 
velops with a time course that closely parallels that of 
synaptogenesis ( a s h  et al., 1989), which is compatible 
with the supposition that vesicular glutamate uptake 
plays an important role in synaptic function. In view 
of the potential importance of the vesicular glutamate 
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uptake system in synaptic transmission and normal 
brain function, we began to explore the possibility that 
vesicular glutamate uptake may be regulated. In this 
report, we provide evidence that the vesicular glutamate 
uptake system is regulated by a soluble proteinaceous 
substance. A preliminary account of this study has been 
reported previously (Lobur et al., 1988). 
MATERIALS AND METHODS 
Materials 
~-[2,3-~H]Glutamic a id (46 Ci/mmol), L-glutamic acid, 
and DEAE Bio-Gel A ( 100-200 mesh) were purchased from 
Amersham, Sigma, and Bio-Rad, respectively. 
Preparation of crude synaptic vesicles and 
synaptosomal cytosol 
Synaptic vesicles were prepared from 30-day-old rat ce- 
rebrum using the method of Kish and Ueda (1989). The tissue 
was homogenized in 10 volumes of solution A containing 
0.32 M sucrose, 0.5 mM calcium acetate, 1 mM magnesium 
acetate, and 1 mM NaC03, and the homogenate was cen- 
trifuged at 12,100 g, (10,000 rpm, Sorvall SS-34 rotor). 
The pellet (a crude synaptosomal fraction) was resuspended 
in 20 volumes of ice-cold lysing solution (6 mMTris-maleate, 
pH 8.1) for 45 min, and centrifuged at 43,500 g,,, (19,000 
rpm, Sorvall SS-34 rotor) for 15 min to pellet synaptic and 
mitochondria1 membranes. The supernatant was then cen- 
trifuged at 200,000 g,,, (41,000 rpm, Beckman Ti45 rotor) 
for 70 min. The crude vesicle pellets were resuspended in 
solution B containing 0.32 M sucrose, 1 m M  dithiothreitol, 
and 1 mM NaHC03 (0.5 pl/mg of original wet tissue). The 
supernatant was collected and used as a crude synaptosomal 
cytosolic fraction. This cytosolic fraction contained the in- 
hibitory factor. Bovine vesicles and synaptosomal cytosolic 
fractions were prepared in the same manner as described by 
Kish and Ueda (1989). 
Protein was determined using the method of I ~ w r y  et al. 
( 1  95 1) with bovine serum albumin as the standard. 
Standard assay for vesicular glutamate uptake 
The uptake of glutamate into crude vesicles was assayed 
as previously described (Naito and Ueda, 1983, 1985) with 
slight modifications. The standard uptake medium (final vol- 
ume, 100 pl) contained 0.25 M sucrose, 10 mM MgSO.,, 5 
mM HEPES (pH 7.4), 20 mM aspartate, 4 mM KCI, 50 pg 
of rat crude synaptic vesiclcs, 0 or 7 m M  ATP (neutralized 
to pH 7.4 with Tris base), unlabeled glutamate, and 
['Hlglutamate (500 p M  specific activity, 0.04 Ci/mmol). 
Uptake was initiated by the addition of a mixture (20 ~ 1 )  
containing ATP and labeled and unlabeled glutamate. The 
mixture was incubated at 30°C for 5 min, followed by the 
addition of 2 ml of ice-cold 0.15 M KC1 and immediate fil- 
tration through Millipore HAWP filters (25 mm, 0.45 pm). 
The test tubes were washed three more times and the filters 
an additional three times with ice-:old KCI. The radioactivity 
retained on the filters was quantified using a liquid scintil- 
lation spectrophotometer. Glutamate uptake activity in the 
absence of ATP was subtracted from the activity in the pres- 
ence of ATP. Control uptake activity was defined as the ATP- 
dependent uptake activity determined in the absence of the 
inhibitory factor. ATP-dependent glutamate uptake and in- 
hibitory activity also could be demonstrated using I25 mM 
potassium isethionate, or 63 m M  potassium tartrate and 6 1 
mM sucrose, in place of 0.25 M sucrose. 
Assay of the inhibitory factor 
Vesicular glutamate uptake was measured in the presence 
and absence of the factor as described above. One unit of the 
inhibitory factor is defined as the amount of factor required 
to inhibit ATP-dependent uptake by 50%. The inhibitory 
factor had little effect on the glutamate uptake observed in 
the absence of ATP. 
Ammonium sulfate precipitation of the 
inhibitory factor 
The presence of a soluble inhibitory factor was first detected 
in the crude synaptosomal cytosol. Solid ammonium sulfate 
was added to a constantly stirred synaptosomal cytosol frac- 
tion, to 40% saturation, at 4°C. Addition took 25 min. The 
solution was allowed to stand on ice for an additional 30 
min, stirred briefly, and centrifuged at 20,000 g,, for 20 
min. The pellet was resuspended in a minimal volume of 10 
mMTris-maleate (pH 7.0) and dialyzed overnight against at 
least 1,000 volumes of 10 mM Tris-maleate (pH 7.0). Most 
of the inhibitory activity (82%) was fractionated in the pre- 
cipitate from 40% saturation with ammonium sulfate. This 
material was used in all experiments. 
RESULTS 
Effect of various concentrations of the 
inhibitory factor 
The partially purified factor inhibited ATP-depen- 
dent glutamate uptake in a concentration-dependent 
manner (Fig. 1). The ammonium sulfate fractionation 
resulted in an approximate twofold increase in specific 
activity. Complete inhibition has never been observed. 
It is possible that the residual activity (about 20%) rep- 
resents a subtype of the vesicular glutamate uptake sys- 
tem that is insensitive to the endogenous inhibitory 
factor. 
Characterization of the inhibitory factor 
Charge, size, and thermal stability. The ammonium 
sulfate fractionate was passed over a DEAE Bio-Gel A 
0 1 2 3 
AMMONIUM SULFATE PRECIPITATE 
(mg of protein) 
FIG. 1. Effect of various concentrations of the inhibitory factor on 
vesicular glutamate uptake. Vesicular glutamate uptake was as- 
sayed, under standard conditions, with the addition of various 
amounts of the 40%-saturated ammonium sulfate precipitate (0.23- 
2.7 mg of protein). These uptake values are expressed as per- 
centage of ATP-dependent uptake activity observed in the absence 
of ammonium sulfate precipitate (control). The glutamate uptake 
in t h e  control was 217.8 k 3.5 pmol/5 min/50 pg of protein. 
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column. Part of the inhibitory activity was detected in 
the flow-through material, which was not retained on 
the column, and a portion of the inhibitory activity 
was eluted with 0.13-0.26 M KCl (data not shown). 
This suggests that there may be two inhibitory factors, 
one basic and one acidic. When the acidic inhibitory 
factor was subjected to gel filtration on a Bio-Gel P- 
100 column, it was found in the void volume fractions, 
suggesting a molecular weight > 100,000 (data not 
shown). When the ammonium sulfate was subjected 
to heat treatment, most of the inhibitory activity was 
lost within the first minute of heating to IOO°C. In 
contrast, the inhibitory activity was stable at room 
temperature for at least 4 h (data not shown). 
Efects of treatment with proteolytic enzymex The 
effects of trypsin and chymotrypsin treatments on the 
inhibitory activity are shown in Table 1. Neither en- 
zyme was able to abolish the inhibitory activity. In 
fact, trypsin treatment appears to result in a slight in- 
crease in the inhibitory activity (Fig. 2). 
The data in Table 2 demonstrate the thermal stability 
of the chymotrypsin digest of the inhibitory factor. In 
contrast with the native inhibitory factor, the chymo- 
tryptic digest is resistant to inactivation by heat 
(l0OOC). The control sample, which was not treated 
with chymotrypsin, demonstrated approximately 80% 
inhibitory activity. Inactivated chymotrypsin alone had 
no effect on glutamate uptake. The chymotrypsin- 
treated factor had inhibitory activity comparable to that 
of the untreated factor. It is interesting that upon treat- 
ment at 1 OO’C, the chymotrypsin-treated sample re- 
tained its original inhibitory activity, whereas the un- 
treated sample lost the activity. 
Species and tissue specijicity. In experiments not 
presented here, the soluble inhibitory factor prepared 
TABLE 1. Effect of treatment with trypsin or chymotrypsin 
on the inhibitory.factor 
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FIG. 2. Effect of trypsin treatment on inhibitory activity present in 
ammonium sulfate (AS) precipitate. The ammonium sulfate precip- 
itate (10.5 mg of protein) was incubated with trypsin (0.1 mg/ml). 
as described in the footnote to Table 2, in a final volume of 0.35 
ml. The tryptic digestion was stopped with the addition of Bowman- 
Birk trypsin-chymotrypsin inhibitor (0.1 rnglml). Various aliquots of 
the digested material (6)  and the undigested inhibitory factor (0) 
were assayed for their ability to inhibit vesicular glutamate uptake. 
Control glutamate uptake was 246.6 f 5.3 pmol/5 min/50 pg of 
protein. 
from the rat brain exhibited a similar inhibitory activity 
in bovine synaptic vesicle preparations. Moreover, the 
inhibitory factor was shown to be present not only in 
the rat brain but also in the bovine brain. 
A fraction comparable to the crude synaptosomal 
cytosol was prepared from rat “nonnervous” tissue, 
such as liver, kidney, and lung, as well as from brain, 
and subjected to ammonium sulfate fractionation. 
Each ammonium sulfate fractionate was then tested 
for the ability to inhibit vesicular glutamate uptake. Of 
the tissues tested, the inhibitory activity was detected 
in only brain tissue (data not shown). Within the brain, 
the inhibitory activity varied by region. The sample 
derived from the cerebral cortex exhibited 70% inhi- 
bition of the vesicular glutamate uptake, whereas 
Additions 
Glutamate uptake 
(% of control) 
TABLE 2. Effect ofboiling on the chymotrypsin-treated 
inhibitory factor 
None (control) 100 
AS precipitate 37 * 2 
Trypsin 97 * 2 
Trypsin-treated AS precipitate 20 k 1 
Chymotrypsin 90 f 4 
Chymotrypsin-treated AS precipitate 30 -C 0.2 
The 40%-saturated ammonium sulfate precipitate (AS precipitate, 
4.5 mg of protein) was incubated at 30°C for 5 min in the presence 
and absence of trypsin or chymotrypsin (0.1 mg/ml), in a final volume 
of 200 p1 containing 7.5 mM Tris-maleate (pH 7.0). Trypsin or chy- 
motrypsin alone also was subjected to the same incubation conditions. 
After incubations, Bowman-Birk trypsin-chymotrypsin inhibitor was 
added to a final concentration of 0.1 mg/ml. Aliquots (30 PI)  of 
sample from each reaction mixture were assayed for the ability to 
inhibit vesicular glutamate uptake. These values are expressed as 
percentage of control uptake activity (220.7 f 11.6 pmol/5 min/50 
pg of protein). In experiments not shown here, the trypsin-chymo- 




(% of control) 
None (control) 100 
AS precipitate 23 f 3 
Chymotrypsin 99 F 2 
Chymotrypsin-treated AS precipitate 22 * I 
17 f 0.8 
Chymotrypsin-treated AS precipitate, boiled 43 & 5 
AS precipitate, boiled 
The 40%-saturated ammonium sulfate precipitate (AS precipitate, 
4.5 mg of protein) was incubated at 30°C for 5 min in the presence 
or absence of 0. I mg/ml chymotrypsin, in a final volume of 200 pl. 
Chymotrypsin alone or the precipitate alone also was subjected to 
the same incubation conditions. After incubation, chymotrypsin in- 
hibitor was added to a final concentration of 0. I mg/ml. The chy- 
motrypsin-treated, as well as the nontreated, precipitates were then 
heated to 100°C for 2 min. Aliquots (30 pl) of each sample were 
assayed for the ability to inhibit vesicular glutamate uptake. Control 
glutamate uptake was 230.5 f 14.6 pmol/5 min/50 pg of protein. 
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equivalent samples prepared from the hippocampus, 
caudate nucleus, cerebellum, and brainstem showed 
about 40% inhibition (Fig. 3) .  
DISCUSSION 
In this study, we have provided evidence for the ex- 
istence of an endogenous inhibitory factor for vesicular 
glutamate uptake. The principal inhibitory factor is 
precipitated by ammonium sulfate (40% saturation), 
and appears to be an acidic substance with a molecular 
weight > 100,000. Furthermore, the inhibitory factor 
is stable at room temperature, but labile at 1OO"C, and 
is resistant to treatment with trypsin and chymotrypsin. 
It is interesting that, after chymotryptic treatment, 
inhibitory activity survived heating to 1 OO"C, suggest- 
ing that chymotryptic treatment yielded fragments of 
the inhibitory factor that were no longer inactivated at 
100°C. These observations, together with the obser- 
vation that the native inhibitory factor is excluded from 
Bio-Gel P-100, support the view that the factor is a 
proteinaceous substance that is cleaved to an active, 
heat-stable fragment by the proteolytic enzyme. 
The tissue distribution studies indicate that the in- 
hibitory factor is present predominantly in the brain, 
and, within the brain, occurs in various regions, in- 
cluding the cerebral cortex, hippocampus, caudate nu- 
cleus, and cerebellum, all of which are knowr, to be 
rich in glutamatergic synapses (Greenamyre et al., 
1984; Cotman et al., 1987). The factor is present not 
only in the rat brain but also in the bovine brain, and 
is capable of inhibiting glutamate uptake into both rat 
and bovine synaptic vesicles. These results suggest that 
a similar, if not identical, proteinaceous, inhibitory 
substance occurs in the brains of other species, and 
raise the possibility that such an endogenous factor 
Hippocapus Caudale cerebral Cerebdlurn Braistern 
ORIGIN OF AMMONIUM SULFATE FRACTION 
Nucleus Cnrfex 
FIG. 3. Regional distribution of the inhibitory factor in rat brain. 
Ammonium sulfate (40% saturation) precipitates were prepared 
identically from synaptosornal cytosol from rat hippocampus, cau- 
date nucleus, cerebral cortex, cerebellum, and brainstem. Aliquots 
containing equal amounts of protein (0.25 rng) from each region 
were assayed for their ability to inhibit vesicular glutamate uptake. 
The data shown represent the mean f SD of two preparations. 
Control glutamate uptake was 214.4 k 8.7 pmol/5 min/50 pg of 
protein. 
could be involved in modulating the accumulation of 
glutamate into synaptic vesicles in vivo. 
The mechanism by which the inhibitory factor 
achieves its effect is not understood at present. At least 
six possible mechanisms can be considered. First, the 
possibility that the inhibitory factor could be simply 
enzymatically degrading the glutamate uptake system 
is unlikely, as none of the protease inhibitors tested 
were able to diminish the inhibitory effect at concen- 
trations known to inhibit proteolysis; these included 
soybean trypsin inhibitor (100 pg/pl), EGTA (1 M), 
phenylmethanesulfonyl fluoride ( 100 p M ) ,  diisopropyl 
fluorophosphate (1 mM), and leupeptin (50 p M )  (data 
not shown). Second, the factor could be an ATPase, 
which may substantially reduce ATP levels and thereby 
lead to an apparent inhibition. This possibility is also 
unlikely, as treatment of the crude synaptosomal cy- 
tosol at 60°C for 5 min totally abolished ATPase ac- 
tivity in the synaptosomal cytosol, but left approxi- 
mately half the inhibitory activity intact. Treatment of 
the crude cytosol at 50°C for 5 min abolished more 
than half the ATPase activity, with 15% reduction in 
the inhibitory activity (data not shown). Moreover, the 
inhibitory activity of the factor was not abolished by 
increasing the concentration of ATP to 20 mM. Third, 
the factor could be inhibiting ATP hydrolysis by the 
proton-pump ATPase in the vesicle membrane. This 
possibility also is unlikely because the factor did not 
affect the Mg-ATPase activity associated with the syn- 
aptic vesicles. Fourth, the factor could block the gen- 
eration of membrane potential by interfering with pro- 
ton translocation. Fifth, the factor could diminish glu- 
tamate uptake by blocking the chloride-induced 
stimulation. This possibility is unlikcly, as the factor 
inhibited ATP-dependent uptake even in the absence 
of chloride (data not shown). Finally, the factor could 
inhibit glutamate uptake by binding to the putative 
glutamate translocator, distinct from the proton-pump 
ATPase. Thus, further studies are required to better 
understand the mechanism of action of the inhibitory 
factor. 
It is well known that catecholamine uptake into 
storage vesicles is inhibited by reserpine, which results 
in reduction of adrenergic transmission (Weiner, 1970; 
Rand and Jurevics, 1977). Recently, regulation of 
transmitter uptake into synaptic vesiclcs derived from 
Torpedo electric organ has been described by Parsons 
et al. (1987). Although substances exist that affect the 
vesicular storage of transmitters, this is, to the best of 
our knowledge, the first report of an endogenous reg- 
ulatory factor. 
Regulation of glutamatergic synaptic transmission 
at the site of the postsynaptic receptors has been ex- 
tensively studied, especially with respect to the N- 
methyl-D-aspartate receptor complex (Ascher and No- 
wak, 1987; Cotman and Iversen, 1987; Kemp et al., 
1987; Watkins and Olverman, 1987). In contrast with 
the postsynaptic modulation of glutamate transmis- 
sion, relatively little is known about the regulation of 
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presynaptic vesicular glutamate. It has been observed 
that vesicular glutamate uptake is stimulated by low 
concentrations of chloride and inhibited by high con- 
centrations (Naito and Ueda, 1985). Shank and 
Campbell ( 1984) have shown that glutamate and glu- 
tamine affect the uptake of a-ketoglutarate, one of the 
proposed precursors of glutamate, into synaptosomes 
and astrogliasomes. This suggests that these amino ac- 
ids may regulate the metabolic pool, and possibly the 
neurotransmitter pool, of glutamate. However, it re- 
mains to be seen whether the increase in glutamate 
concentration in the synaptic cleft upon evoked release 
indeed leads to  a significant change in the neurotrans- 
mitter pool of glutamate. although it could regulate its 
metabolic pool. On the other hand, direct inhibition 
of the active transport system in the synaptic vesicle 
by an endogenous substance, such as the protein factor 
studied here or chloride ions, could represent a more 
effective means of modulating the transmitter pool of 
glutamate. Thus, the endogenous proteinaceous factor 
may serve a function in the regulation of the transmitter 
pool of glutamate. If the net content of glutamate ac- 
cumulated into the synaptic vesicle is rcgulated, this 
regulation could result in an alteration in the level of 
glutamate released into the synapse upon depolariza- 
tion, and thereby could modulate glutamate transmis- 
sion. In extreme cases, breakdown of such a modula- 
tory system could lead to derangements in glutama- 
tergic transmission. 
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